查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1680771

生物影像市場報告：2031 年趨勢、預測與競爭分析

Bio-Imaging Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球生物影像市場前景光明，診所、診斷中心、醫院和實驗室都充滿機會。預計到 2031 年，全球生物成像市場規模將達到 197 億美元，2025 年至 2031 年的複合年成長率為 15.7%。該市場的主要驅動力是由於成像技術的進步、慢性病盛行率上升和全球人口老化、診斷中心和放射性藥物的增加而對生物成像設備的需求不斷增加。

  • 根據 Lucintel 的預測，由於放射學在急診醫學、整形外科和普通放射學中的應用日益廣泛，預計在預測期內將出現最高成長。
  • 根據最終用途，醫院預計仍將是最大的部分。這是由於基礎設施和先進影像處理設施的顯著發展，使醫院能夠簡化營運。
  • 從地區來看，北美很可能在預測期內繼續保持最大地區地位，因為北美擁有完善的醫療保健體系、先進的醫療設施、不斷上升的癌症和心臟疾病發病率，以及高普及率的健康保險計劃，尤其是在美國。

生物成像市場的策略成長機會

在技​​術創新、更好的診斷需求和醫療技術進步的推動下，生物成像市場正在迎來新的策略成長機會。這些機會對於相關人員進入不斷成長的市場和追求創新至關重要。本節概述了五個特定應用的成長機會及其在生物成像市場和未來醫療保健中的作用。

  • 腫瘤成像：由於癌症發生率的不斷上升，腫瘤成像成為生物成像市場的一個主要成長領域。 PET/CT、PET/MRI 和分子影像等先進影像方式正被用於準確的癌症診斷和治療計劃。人工智慧在腫瘤成像中的整合正在提高腫瘤識別的準確性並實現個人化治療計劃。這一成長機會正在吸引對先進成像解決方案開發的投資，從腫瘤學的角度擴大市場。
  • 神經影像：由於阿茲海默症、帕金森氏症和多發性硬化症等神經系統疾病的盛行率不斷上升，神經影像也是一個主要的成長領域。功能性磁振造影 (fMRI)、擴散張量造影 (DTI) 和 PET 等新影像技術正在用於診斷和評估這些疾病。影像方式也在不斷發展，以滿足對病變和惡性腫瘤的快速篩檢和檢測日益成長的需求。這一趨勢為針對神經病學的成像解決方案創造了成長機會。
  • 心臟病學影像：由於心血管疾病的盛行率不斷上升以及對準確診斷的需求，循環系統影像市場持續成長。使用 3D 和 4D 超音波心動圖、心臟 MRI 和 CT血管造影術等先進的影像技術可以提供無需手術即可評估心臟的安全方法。基於人工智慧的工具也被整合到心臟成像系統中，以增強心臟病診斷並提高業務效率。這一市場的成長正在推動心臟影像技術的進步，從而改善患者照護。
  • 整形外科影像：由於人口老化和肌肉骨骼疾病盛行率上升，整形外科影像市場正在擴大。整形外科影像技術不僅有助於診斷，還可以指南治療計劃和復健。行動影像設備在整形外科實踐中特別有用，因為及時診斷和治療性介入至關重要。這一趨勢增加了對整形外科成像解決方案的需求，並刺激了先進成像技術的發展。
  • 獸醫影像：獸醫影像學是生物影像市場成長的主要貢獻者，這得益於動物保健領域對更先進診斷工具的需求。超音波、MRI 和 CT 等技術擴大應用於獸醫診斷，為動物保健提供非侵入性解決方案。此外，人工智慧主導的獸醫影像解決方案的開發正在提高診斷準確性和工作流程效率。這一成長機會為生物成像市場的擴張開闢了新的途徑。

由於技術進步和對準確有效的診斷工具的需求不斷增加，生物成像市場正在經歷顯著成長。這些趨勢正在為腫瘤學、神經病學、心臟病學、骨科和獸醫學等多個領域創造新的成長機會。

生物影像市場促進因素與挑戰

生物成像市場受到多種市場促進因素和挑戰的影響，包括技術進步、經濟狀況和監管政策。這些因素在決定市場成長、客戶對成像技術的接受度以及行業的整體結構方面發揮關鍵作用。

驅動程式：

  • 成像模式的技術改進：人工智慧、混合模式和無線成像系統等成像技術的不斷改進正在推動生物成像市場的成長。這些技術創新正在提高診斷的準確性和速度，有助於市場擴張。
  • 慢性病發生率上升：癌症、心血管疾病和神經系統疾病等慢性病的發生率不斷上升，推動了對先進診斷影像技術的需求。快速準確診斷的需求推動了尖端成像技術的採用。
  • 越來越關注標靶醫療：個人化醫療的日益成長趨勢推動了對高解析度先進成像系統的需求，包括 3D 和 4D 成像。這些技術可以實現更個人化的治療方法，進而改善患者的治療效果。
  • 增加醫療保健支出：政府和私人投資者增加醫療保健支出正在推動先進成像技術的使用。醫療設施的發展，尤其是新興國家的醫療設施的發展，正在為成像解決方案供應商創造新的成長機會。
  • 有利的監管核准和報銷政策：監管核准和報銷制度正在加速侵入性成像技術的採用，並鼓勵對創新設備開發的投資。

任務：

  • 先進影像系統高成本：先進診斷影像系統的高成本是一個重大挑戰，尤其是在醫療保健預算有限的新興國家。這一障礙阻礙了尖端成像技術的採用，減緩了市場成長。
  • 資料隱私和安全問題：隨著雲端基礎的影像處理平台和支援人工智慧的應用程式的採用率不斷提高，資料隱私和安全問題也日益嚴重。遵守法規和保護敏感資料對於建立醫療保健提供者和患者之間的信任關係至關重要。
  • 缺乏熟練的勞動力：生物成像領域缺乏熟練的專業人員，阻礙了先進成像技術的充分利用。這項挑戰在缺乏操作先進影像處理系統專業知識的開發中地區尤為明顯。

生物成像市場面臨的促進因素和促進因素將塑造未來的市場趨勢，並影響新技術的發展和成像服務的擴展。應對這些挑戰將使相關人員能夠利用市場上的新機會。

目錄

第1章執行摘要

第2章全球生物影像市場：市場動態

  • 簡介、背景和分類
  • 供應鏈
  • 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

  • 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
  • 全球生物影像市場趨勢（2019-2024）及預測（2025-2031）
  • 全球生物成像市場類型
    • 彈性成像
    • 磁振造影（MRI）
    • 醫學超音波/超音波
    • X光
  • 全球生物成像市場（按技術）
    • 藥品
    • 分子
  • 全球生物成像市場（按最終用途分類）
    • 診所
    • 診斷中心
    • 醫院
    • 研究所

第4章區域市場趨勢與預測分析（2019-2031）

  • 全球生物成像市場（按地區）
  • 北美生物成像市場
  • 歐洲生物成像市場
  • 亞太生物成像市場
  • 其他地區的生物成像市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球生物成像市場成長機會（按類型）
    • 全球生物成像市場成長機會（按技術）
    • 全球生物成像市場成長機會（按最終用途分類）
    • 全球生物成像市場各區域成長機會
  • 全球生物成像市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球生物成像市場的生產能力
    • 全球生物成像市場的企業合併
    • 認證和許可

第7章主要企業簡介

  • Bioclinica
  • Bracco Imaging
  • FONAR
  • Bayer Healthcare Pharmaceuticals
  • Covidin corp
  • GE Healthcare
  • GammaMedica
簡介目錄

The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $19.7 billion by 2031 with a CAGR of 15.7% from 2025 to 2031. The major drivers for this market are the increasing demand for bioimaging instruments as an advancement in the imaging technologies, the rising prevalence of chronic diseases and the a aging world population, and the increasing number of diagnostic centers and radiopharmaceuticals.

  • Lucintel forecasts that, within the type category, X-ray radiography is expected to witness the highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.
  • Within the end use category, hospitals will remain the largest segment due to significantly growing developed infrastructure and advanced imaging facilities that enable hospitals to streamline their operations.
  • In terms of regions, North America will remain the largest region during the forecast period due to the presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardiac diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Bio-Imaging Market

The bio-imaging industry is undergoing significant changes driven by new trends expected to transform the market. These trends are influenced by advancements in technology, the increasing demand for reliable and rapid diagnosis, and the integration of emerging modalities with artificial intelligence (AI) and machine learning. Several general trends are emerging as the market evolves. Some of the visible trends include the adoption of hybrid imaging techniques, developments in portable imaging solutions, and the utilization of cloud-based platforms. This section highlights five key emerging trends in the bio-imaging market, focusing on their implications for access to health services, diagnostic accuracy, and market growth.

  • Integration of Imaging with AI: The integration of imaging with AI is a rapidly growing trend in the bio-imaging market, leading to improved accuracy and efficiency in imaging solutions. By utilizing deep learning technologies, AI can identify shapes and contours that may be missed by the human eye, especially in detecting diseases at early stages. AI also enables real-time analysis, reducing delays in diagnostics and facilitating faster decision-making. AI imaging tools are becoming more prominent in individualized treatment planning, where treatment approaches are based on patient-specific imaging data. This trend is accelerating the development of new imaging techniques and enhancing healthcare processes.
  • Overlapping Imaging Technologies: Market intelligence reports indicate that the application of overlapping imaging technologies, such as PET/MRI and SPECT/CT, is becoming increasingly important. These systems combine the advantages of multiple imaging modalities to create comprehensive central images, improving diagnostic accuracy. For example, PET/MRI combines PET imaging of metabolic changes with MRI imaging of soft tissue structures, providing both functional and anatomical insights into pathological processes. Hybrid imaging is particularly beneficial for diagnosing cancer, heart disease, and brain conditions, where understanding both the problem and its treatment is critical. This development is contributing to the emergence of more flexible and advanced imaging systems.
  • Portable and Point-of-Care Imaging Devices: The demand for portable and point-of-care imaging devices is rising, particularly in rural and remote areas where healthcare facilities require portable and easy-to-use solutions. Devices like portable ultrasound and handheld MRI are enabling doctors to conduct bedside diagnostics, providing faster and more convenient care for patients. These devices are especially important in emergencies, where rapid diagnostics can save lives. Additionally, advancements in miniaturization and wireless technology are enhancing the functionality of portable imaging systems, making them an integral part of modern healthcare.
  • Platforms for Imaging Hosted in the Cloud: Cloud-based imaging platforms are transforming how imaging data is captured, stored, shared, and analyzed. These platforms enable integration with electronic health records and telehealth systems, providing users with access to imaging data regardless of their location. One of the key advantages of cloud platforms is collaborative diagnostics, where multiple healthcare providers can access and interpret the same data simultaneously. These platforms also address concerns related to data ownership, security, and access, making them a critical trend in the bio-imaging industry. As data privacy and security issues are resolved, this trend is expected to grow.
  • Precision Oncology as a Course of Action in Theragnostic Research and Molecular Imaging: Molecular imaging and theragnostics are becoming increasingly important in oncology. These technologies enable imaging of both anatomical and pathological processes in the body, highlighting changes that can guide treatment decisions. The use of theragnostic agents, which combine diagnostic and therapeutic functions, is leading to more personalized treatments. The growing use of PET/CT and PET/MRI as molecular imaging techniques is facilitating the development of improved targeted radiopharmaceuticals for both diagnostic and therapeutic purposes.

The trends observed in the bio-imaging sector are transforming how healthcare services are delivered by increasing diagnostic and treatment efficiency, reducing costs, and enhancing patient satisfaction. These trends play a key role in driving the growth and advancement of the market, opening up new opportunities for market players.

Recent Developments in the Bio-Imaging Market

The bio-imaging market is undergoing significant changes that are reshaping its structure. Key developments include the integration of new imaging systems with AI, as well as strategic partnerships that are boosting market progress. The entry of miniaturized imaging devices, networked applications, and novel imaging modalities is enabling more accurate and timely diagnoses. These improvements are essential for the healthcare system, ensuring better patient care, streamlining processes, and supporting targeted treatments. This section focuses on five key areas of growth within the bio-imaging industry.

  • AI-Based Imaging Tools: New AI-based imaging tools are making diagnoses more effective and expediting analysis in the bio-imaging industry. These tools use algorithms and data analysis to enhance the screening process for various diseases. AI-enhanced imaging devices are also helping develop patient-specific treatment plans, particularly for cancer and neurological diseases. This growing use of modern imaging technologies is creating a market for AI-powered bio-imaging solutions.
  • Introduction of Cloud-Based Imaging Platforms: The introduction of cloud-based imaging platforms is a significant development in the bio-imaging industry. These platforms enable the secure storage, sharing, and analysis of imaging data, fostering collaboration among healthcare providers. Remote access to imaging data is particularly important for telemedicine and remote diagnostics. These platforms also address challenges related to data storage and management, offering solutions that meet the needs of users while accommodating increasing volumes of digital health tools.
  • Introduction of Hybrid Imaging Systems: Hybrid imaging systems, such as PET/CT, PET/MRI, and SPECT/CT, combine multiple imaging modalities to provide a more comprehensive view of the body. The information from these systems is integrated to deliver both anatomical and functional insights, enhancing diagnostic accuracy. Hybrid imaging is particularly useful in oncology, cardiology, and neurology, where diagnostic precision is critical. The next generation of hybrid imaging systems is expected to bring further innovation and market expansion.
  • Collaboration and Strategic Partnerships: Innovation in the bio-imaging market is being driven by collaboration and strategic partnerships between key players, including medical device companies, research institutions, and service providers. These partnerships are helping to accelerate the development and adoption of new imaging technologies.

Recent developments in bio-imaging, such as improvements in non-invasive probes, are enhancing the capabilities of imaging systems, improving patient treatment, and driving market growth. These developments are creating favorable conditions for stakeholders and offering new opportunities within the healthcare sector.

Strategic Growth Opportunities for Bio-Imaging Market

The bio-imaging market is identifying new strategic growth opportunities, driven by technological innovation, the demand for better diagnosis, and advancements in healthcare technology. These opportunities are crucial for stakeholders entering the growing market and pursuing innovations. This section outlines five growth opportunities by application and their roles in the bio-imaging market and the future of healthcare.

  • Oncology Imaging: Oncology imaging is a major growth segment in the bio-imaging market due to the increasing incidence of cancer. Advanced imaging devices such as PET/CT, PET/MRI, and molecular imaging are used for accurate cancer diagnosis and treatment planning. The integration of AI in oncology imaging is improving the precision of tumor identification and enabling personalized treatment plans. This growth opportunity is attracting investment in the development of advanced imaging solutions, expanding the market from an oncology perspective.
  • Neurology Imaging: Neurology imaging is another key growth segment due to the rising prevalence of neurological conditions such as Alzheimer's, Parkinson's disease, and multiple sclerosis. New imaging techniques, including functional MRI (fMRI), diffusion tensor imaging (DTI), and PET, are being used to diagnose and assess these diseases. Imaging methods are also evolving to meet the growing demand for rapid screening and detection of lesions and malignancies. This trend is creating growth opportunities for imaging solutions targeting neurology.
  • Cardiology Imaging: The cardiology imaging market continues to grow due to the increasing incidence of cardiovascular diseases and the need for accurate diagnosis. The use of advanced imaging techniques such as 3D and 4D echocardiography, cardiac MRI, and CT angiography is providing safer ways to assess the heart without surgery. AI-based tools are also being integrated into cardiology imaging systems to enhance the diagnosis of heart diseases and improve operational efficiency. This market growth is spurring advances in cardiac imaging technologies, improving patient care.
  • Orthopedic Imaging: The orthopedic imaging market is expanding due to the aging population and the rising prevalence of musculoskeletal disorders. Imaging techniques in orthopedics are not only helping with diagnosis but also guiding treatment planning and rehabilitation. Mobile imaging devices are particularly valuable in orthopedic practices, where timely diagnostics and therapeutic interventions are critical. This trend is increasing the demand for orthopedic imaging solutions and driving the development of advanced imaging techniques.
  • Veterinary Imaging: Veterinary imaging is emerging as a key contributor to the growth of the bio-imaging market, driven by the demand for more sophisticated diagnostic tools in the animal health sector. Techniques such as ultrasound, MRI, and CT are increasingly being used for veterinary diagnostics, offering non-invasive solutions for animal care. Additionally, the development of AI-driven imaging solutions for veterinary care is enhancing diagnostic accuracy and workflow efficiency. This growth opportunity is unlocking new avenues for expansion in the bio-imaging market.

The bio-imaging market is experiencing significant growth due to advancements in technology and the increasing demand for accurate and effective diagnostic tools. These trends are creating new growth opportunities in various sectors, including oncology, neurology, cardiology, orthopedics, and veterinary care.

Bio-Imaging Market Driver and Challenges

The bio-imaging market is influenced by several drivers and challenges, including technological advancements, economic conditions, and regulatory policies. These factors play a crucial role in determining market growth, customer acceptance of imaging technologies, and the overall structure of the industry.

Drivers:

  • Technological Improvements in Imaging Modalities: Continuous improvements in imaging technologies, such as the integration of AI, hybrid modalities, and wireless imaging systems, are driving growth in the bio-imaging market. These innovations are improving diagnostic accuracy and speed, contributing to market expansion.
  • Rising Incidence of Chronic Diseases: The growing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological conditions, is increasing the demand for advanced imaging techniques. The need for swift and accurate diagnosis is driving the adoption of state-of-the-art imaging technologies.
  • Increased Interest in Targeted Medicine: The growing trend of personalized medicine is driving demand for advanced imaging systems with high resolution, such as 3D and 4D imaging. These technologies are enabling more tailored therapeutic approaches, leading to better patient outcomes.
  • Increase in Health Expenditure: Rising healthcare spending from both national governments and private investors is promoting the use of advanced imaging techniques. The improvement of healthcare facilities, especially in developing countries, is opening new growth opportunities for imaging solution providers.
  • Favorable Regulatory Approvals and Reimbursement Policies: Regulatory approvals and reimbursement schemes are facilitating the adoption of invasive imaging technologies and encouraging investment in innovative equipment development.

Challenges:

  • High Cost of Advanced Imaging Systems: The high cost of advanced imaging systems is a major challenge, especially in developing countries with limited medical budgets. This barrier reduces the adoption of cutting-edge imaging technologies, slowing market growth.
  • Concerns About Data Privacy and Security: The increased adoption of cloud-based imaging platforms and AI-powered applications has raised concerns about data privacy and security. Ensuring compliance with regulations and protecting sensitive data is critical to building trust among healthcare providers and patients.
  • Shortage of Skilled Workforce: A shortage of skilled professionals in the bio-imaging sector is preventing the full utilization of advanced imaging technologies. This challenge is particularly prevalent in developing regions, where expertise in operating sophisticated imaging systems is limited.

The drivers and challenges facing the bio-imaging market will shape its future trends, influencing the development of new technologies and the expansion of imaging services. Addressing these challenges will help stakeholders leverage emerging opportunities in the market.

List of Bio-Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-imaging companies profiled in this report include-

  • Bioclinica
  • Bracco Imaging
  • Fonar
  • Bayer Healthcare Pharmaceuticals
  • Covidin
  • GE Healthcare
  • Gammamedica

Bio-Imaging by Segment

The study includes a forecast for the global bio-imaging market by type, technology, end use, and region.

Bio-Imaging Market by Type [Analysis by Value from 2019 to 2031]:

  • Elastography
  • Magnetic Resonance Imaging
  • Medical Ultrasonography or Ultrasound
  • X-Ray Radiography

Bio-Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

  • Medical
  • Molecular

Bio-Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

  • Clinics
  • Diagnostic Centers
  • Hospitals
  • Laboratories

Bio-Imaging Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Bio-Imaging Market

The global bio-imaging market is undergoing significant advancements due to technological innovations, increased healthcare spending, and the rising demand for accurate diagnosis. Countries such as the United States, China, Germany, India, and Japan are at the forefront of these developments, each contributing distinct advancements that will impact the global market. Key trends include the introduction of AI, the exploration of new imaging modalities, and the formation of alliances among industry players. This section summarizes the developments in each of these countries, highlighting key trends and advancements in the bio-imaging sector.

  • United States: The bio-imaging market in the United States is rapidly evolving, with a strong focus on integrating AI into imaging technologies. Partnerships between companies and research institutions are driving innovation, especially in the early diagnosis of diseases like cancer and neurological disorders. The U.S. FDA's approval of new imaging devices has improved diagnostic capabilities, while public interest in personalized medicine is pushing the demand for modern 3D and 4D imaging systems. Additionally, there is growing interest in cloud-based solutions for remote diagnostics.
  • China: China's bio-imaging market is growing quickly, fueled by expanding healthcare infrastructure and a focus on local innovation. The country is adopting advanced imaging techniques, including molecular imaging and AI-based diagnostic tools. Chinese companies are forming alliances with international firms to enhance technological capabilities. Government policies supporting medical device innovation have led to the production of cost-effective yet sophisticated imaging systems. An aging population and the rising incidence of chronic diseases are further driving the demand for bio-imaging solutions.
  • Germany: Germany continues to be a leader in the bio-imaging market, benefiting from its high-quality healthcare system and innovative developments. Recent advancements include the use of computer-aided detection (CAD) and image analysis (IA) systems to improve diagnostic performance. The adoption of hybrid imaging systems, such as PET/MRI and SPECT/CT, is also on the rise. Collaboration between hospitals, research institutions, and companies is fostering innovation, particularly in precision medicine for cancer and neurological diseases.
  • India: India is experiencing steady growth in the bio-imaging market, with a focus on cost-effective and high-quality imaging solutions. The demand for imaging tools is increasing in rural areas, where remote diagnostics and AI-powered systems are playing a significant role. Government initiatives, such as the "Make in India" program, are promoting the development of homegrown bio-imaging technologies, making them more affordable and accessible. Public-private partnerships are also helping expand the availability of advanced imaging systems across the country.
  • Japan: Japan's bio-imaging market is advancing rapidly, with a strong emphasis on new technologies such as 4D MRI and high-frequency ultrasound for better diagnostic imaging. The government is actively supporting the development of advanced imaging systems, and portable imaging devices combined with AI are becoming increasingly popular, especially for elderly care. Research on the longitudinal adoption of these technologies is also underway, with a focus on early diagnosis and patient comfort.

Features of the Global Bio-Imaging Market

Market Size Estimates: Bio-imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Bio-imaging market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Bio-imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the bio-imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bio-imaging market by type (elastography, magnetic resonance imaging, medical ultrasonography or ultrasound, and X-ray radiography), technology (medical and molecular), end use (clinics, diagnostic centers, hospitals, and laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bio-Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Bio-Imaging Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Bio-Imaging Market by Type
    • 3.3.1: Elastography
    • 3.3.2: Magnetic Resonance Imaging
    • 3.3.3: Medical Ultrasonography or Ultrasound
    • 3.3.4: X-ray Radiography
  • 3.4: Global Bio-Imaging Market by Technology
    • 3.4.1: Medical
    • 3.4.2: Molecular
  • 3.5: Global Bio-Imaging Market by End Use
    • 3.5.1: Clinics
    • 3.5.2: Diagnostic Centers
    • 3.5.3: Hospitals
    • 3.5.4: Laboratories

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Bio-Imaging Market by Region
  • 4.2: North American Bio-Imaging Market
    • 4.2.1: North American Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.2.2: North American Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.3: European Bio-Imaging Market
    • 4.3.1: European Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.3.2: European Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.4: APAC Bio-Imaging Market
    • 4.4.1: APAC Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.4.2: APAC Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.5: ROW Bio-Imaging Market
    • 4.5.1: ROW Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.5.2: ROW Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bio-Imaging Market by Type
    • 6.1.2: Growth Opportunities for the Global Bio-Imaging Market by Technology
    • 6.1.3: Growth Opportunities for the Global Bio-Imaging Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bio-Imaging Market by Region
  • 6.2: Emerging Trends in the Global Bio-Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bio-Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bioclinica
  • 7.2: Bracco Imaging
  • 7.3: FONAR
  • 7.4: Bayer Healthcare Pharmaceuticals
  • 7.5: Covidin corp
  • 7.6: GE Healthcare
  • 7.7: GammaMedica